Natural killer cell activity after gynecologic infections with chlamydiaONSRUD, M; QVIGSTAD, E.Acta obstetricia et gynecologica Scandinavica. 1984, Vol 63, Num 7, pp 613-615, issn 0001-6349Article

HLA-DR-restricted antigen-induced proliferation and cytotoxicity mediated by CD4+ T-cell clones from subjects vaccinated with killed M. lepraeMUSTAFA, A. S; QVIGSTAD, E.International journal of leprosy and other mycobacterial diseases. 1989, Vol 57, Num 1, pp 1-11, issn 0148-916XArticle

Lack of cell-mediated a cytotoxicity towards Chlamydia trachomatis infected target cells in humansQVIGSTAD, E; HIRSCHBERG, H.Acta pathologica, microbiologica et immunologica Scandinavica. Section C. Immunology. 1984, Vol 92, Num 3, pp 153-159, issn 0108-0202Article

Squamous cell carcinoma of the cervix stage IB: numbers and reactivities of pelvic lymph node T cellsONSRUD, M; QVIGSTAD, E.Gynecologic oncology (Print). 1985, Vol 20, Num 2, pp 177-183, issn 0090-8258Article

Cell-mediated and humoral immune responses to chlamydial and herpesvirus antigens in patients with cervical carcinomaQVIGSTAD, E; ONSRUD, M; DEGRE, M et al.Gynecologic oncology (Print). 1985, Vol 20, Num 2, pp 184-189, issn 0090-8258Article

Characterization of Chlamydia trachomatis serotypes by human T-lymphocytes clonesQVIGSTAD, E; SKAUG, K; HIRSCHBERG, H et al.Scandinavian journal of immunology (Print). 1985, Vol 21, Num 3, pp 215-220, issn 0300-9475Article

Antigen-specific proliferative human T-lymphocyte clones with specificity for Chlamydia trachomatisQVIGSTAD, E; DIGRANES, S; THORSBY, E et al.Scandinavian journal of immunology (Print). 1983, Vol 18, Num 4, pp 291-297, issn 0300-9475Article

Nine weeks of bedtime diazoxide is well tolerated and improves β-cell function in subjects with Type 2 diabetesQVIGSTAD, E; KOLLIND, M; GRILL, V et al.Diabetic medicine. 2004, Vol 21, Num 1, pp 73-76, issn 0742-3071, 4 p.Article

Antigen-specific T cell clones restricted by DR, DRw53 (MT), or DP(SB) class II HLA molecules. Inhibition studies with monoclonal HLA-specific antibodiesQVIGSTAD, E; GAUDERNACK, G; THORSBY, E et al.Human immunology. 1984, Vol 11, Num 4, pp 207-217, issn 0198-8859Article

Twelve weeks' treatment with diazoxide without insulin supplementation in Type 2 diabetes is feasible but does not improve insulin secretionRADTKE, M; KOLLIND, M; QVIGSTAD, E et al.Diabetic medicine. 2007, Vol 24, Num 2, pp 172-177, issn 0742-3071, 6 p.Article

T-Cell clones with similar antigen specificity may be restricted by DR, MT(DC), or SB class II HLA moleculesQVIGSTAD, E; MOEN, T; THORSBY, E et al.Immunogenetics (New York, NY). 1984, Vol 19, Num 5, pp 455-460, issn 0093-7711Article

Recognition of a particular HLA-DQ heterodimer by a human γ/δ T cell cloneBOSNES, V; QVIGSTAD, E; LUNDIN, K. E. A et al.European journal of immunology. 1990, Vol 20, Num 7, pp 1429-1433, issn 0014-2980, 5 p.Article

Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial designOPPEGAARD, K. S; NESHEIM, B.-I; ISTRE, O et al.BJOG (Oxford. Print). 2008, Vol 115, Num 5, pp 663-663, issn 1470-0328, 1 p.Article

Sequences of four previously undescribed human T-cell receptor β chain variable genesHANSEN, T; QVIGSTAD, E; LUNDIN, K. E. A et al.Tissue antigens. 1991, Vol 38, Num 3, pp 99-103, issn 0001-2815Article

T-cell receptor β usage by 35 different antigen-specific T-cell clones restricted by HLA-Dw4 or -Dw14.1HANSEN, T; QVIGSTAD, E; LUNDIN, K. E. A et al.Human immunology. 1992, Vol 35, Num 3, pp 149-156, issn 0198-8859Article

Close association between the Dw14 (LD40) subtype of HLA-DR4 and a restriction element for antigen-specific T-cell clonesQVIGSTAD, E; THORSBY, E; REINSMOEN, N. L et al.Immunogenetics (New York, NY). 1984, Vol 20, Num 5, pp 583-588, issn 0093-7711Article

Cytotoxic T cells recognizing minor transplantation antigens, and possibly a variant of the HLA-B8 molecule: cause of rejection of an HLA-identical silling kidney transplant?PFEFFER, P. F; QVIGSTAD, E; AHONEN, J et al.Transplantation. 1984, Vol 38, Num 5, pp 517-522, issn 0041-1337Article

Alloreactive T cells recognizing determinants dependent on the DQβ chain of DQw2LUNDIN, K. E. A; QVIGSTAD, E; SOLLID, L. M et al.Tissue antigens. 1989, Vol 34, Num 5, pp 312-316, issn 0001-2815Article

Identification, at the genomic level, of an HLA-DR restriction element for cloned antigen-specific T4 cellsPAULSEN, G; QVIGSTAD, E; GAUDERNACK, G et al.The Journal of experimental medicine. 1985, Vol 161, Num 6, pp 1569-1574, issn 0022-1007Article

Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulationEILERTSEN, A. L; QVIGSTAD, E; ANDERSEN, T. O et al.Maturitas (Amsterdam). 2006, Vol 55, Num 3, pp 278-287, issn 0378-5122, 10 p.Article

Nicotine concentration in the hair of nonsmoking mothers and size of offspringNAFSTAD, P; FUGELSETH, D; QVIGSTAD, E et al.American journal of public health (1971). 1998, Vol 88, Num 1, pp 120-124, issn 0090-0036Article

Antigen-specific T cells restricted by HLA-DQw8 : importance of residue 57 of the DQB chainLUNDIN, K. E. A; QVIGSTAD, E; ROÊNNINGEN, K. S et al.Human immunology. 1990, Vol 28, Num 4, pp 397-405, issn 0198-8859Article

T lymphocyte clones recognizing an HLA-DQw3.2-associated epitope involving residue 57 on the DQβ chainLUNDIN, K. E. A; GAUDERNACK, G; QVIGSTAD, E et al.Human immunology. 1988, Vol 22, Num 4, pp 235-246, issn 0198-8859Article

Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative methodEILERTSEN, A. L; KARSSEMEIJER, N; SKAANE, P et al.BJOG (Oxford. Print). 2008, Vol 115, Num 6, pp 773-779, issn 1470-0328, 7 p.Article

Page / 2